Bernstein Upgrade Sharpens the Stakes for e.l.f. Beauty's Q1 Print

ELF arrives at its August 6 earnings release with one of the most consequential analyst moves of the year landing just hours before the bell.

Bernstein upgraded the stock to Outperform yesterday, nearly doubling its price target to $113 from $60 — a move that stands out both for its size and its timing. That follows a run of bullish target increases from JP Morgan ($94), Jefferies ($100), and Citigroup ($92) over the past three weeks. The weight of analyst sentiment has shifted sharply upward, with the consensus now well above the current price of $86.37. The stock is up 13% over the past month and 6.8% on the week, reflecting that momentum.

Short interest reinforces the less-adversarial setup. Bears have been stepping back for weeks — SI has fallen roughly a third over the past month to 11.3% of the float, down from around 20% in mid-July. Borrow availability has opened up to 380%, meaning there are close to four shares lendable for every one currently borrowed, and cost to borrow is negligible at 0.52%. That is not a market structure that implies coordinated short-side conviction. Options pricing matches the tone: the put/call ratio is 0.49, barely above its 20-day average of 0.47 and well below the 52-week high of 1.31, suggesting call buyers remain in control.

The bull case rests on first-half sales momentum — up 91% year-on-year — and expanding international distribution expected to concentrate in the second half. Bears point to structural softness in the Cheek category, now at a 31% share low, and management's own warnings of tough year-ago comparisons. The ORTEX short score has eased to 54.4 from 64.4 two weeks ago, tracking the retreat in short positioning rather than signalling renewed pressure. CEO Tarang Amin and the Chief Commercial Officer both sold shares in early July at prices well below where the stock trades today — a factual point worth noting, even if the sales may reflect pre-scheduled plans.

The print will test whether the fundamental momentum that drove the analyst consensus higher — and pulled short sellers back from the table — is durable enough to justify a stock that now trades above most of the targets set just a month ago.